🔎 Trials Near Me

Akèy › Kansè fwa (Kasinòm epatoselilè) › Pennsylvania › Philadelphia

Etid klinik pou Kansè fwa (Kasinòm epatoselilè) nan Philadelphia, PA

16 etid pou Kansè fwa (Kasinòm epatoselilè) ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #98, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

National Liver Cancer Screening Trial

Ap rekriteFaz 4
  • University of Pennsylvania, Philadelphia
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06084234

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Ap rekriteFaz 3
  • Research Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06921785

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2
  • Children's Hospital of Philadelphia, Philadelphia
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • University of Pennsylvania, Perelman School of Medicine, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Ap rekriteFaz 3
  • Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi lwen
  • Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07166406

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Ap rekriteFaz 2
  • Thomas Jefferson University, Philadelphia
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Ap rekrite
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Laj 18 a 75 · Tout sèks · Mizajou Jun 17, 2026 · NCT05486572

Y-90 Treatment Response Using Transarterial Radioembolization

Ap rekriteFaz 2
  • Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT07145801

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Ap rekriteFaz 1/2
  • University of Pennsylvania, Philadelphia
Laj 20 a 99 · Tout sèks · Mizajou Apr 20, 2026 · NCT02174549

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma

Ap rekriteFaz 1/2
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT05842174

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Ap rekriteFaz 2
  • University of Pennsylvania, Abramson Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Apr 2, 2026 · NCT05733598

SBRT With Atezo/Bev for HCC

Ap rekriteFaz 1
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Laj 18 a 99 · Tout sèks · Mizajou Feb 20, 2026 · NCT05488522

Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients

Ap rekriteEtid obsèvasyon
  • Thomas Jefferson Hospital, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jan 26, 2026 · NCT05705219

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Ap rekriteFaz 4
  • Albert Einstein Healthcare Network, Philadelphia
Laj 18 a 64 · Tout sèks · Mizajou Jan 22, 2026 · NCT04373564

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Philadelphia
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kansè fwa (Kasinòm epatoselilè) nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.